IR
ZBH icon

Invictus RG’s Zimmer Biomet ZBH Stock Holding History

Invictus RG’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-524
Closed -$65K – 745
2017
Q2 		$65K Sell
524
-2,786
-84% -$330K 0.05% 438
2017
Q1 		$392K Sell
3,310
-188
-5% -$21.3K 0.26% 132
2016
Q4 		$350K Buy
3,498
+2,224
+175% +$238K 0.23% 156
2016
Q3 		$161K Buy
+1,274
New +$157K 0.13% 312

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invictus RG's ZBH Position: Q3 2017 in Review

Invictus RG sold out of Zimmer Biomet (ZBH) in Q3 2017, closing a stake of 524 shares — an estimated $65K sold.

Invictus RG first reported a position in ZBH in Q3 2016 and held it in 4 quarters. The position peaked at $392K in Q1 2017. 818 funds tracked by Wall St. Rank hold ZBH as of Q3 2017.

  • Invictus RG reported no remaining Zimmer Biomet position as of Q3 2017 after selling out during the quarter.
  • Invictus RG sold 524 Zimmer Biomet shares in Q3 2017, an estimated $65K.
  • Invictus RG first reported a position in Zimmer Biomet in Q3 2016 and held it in 4 quarters.
  • Invictus RG's Zimmer Biomet position peaked at $392K in Q1 2017.
  • 818 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2017.

Based on Invictus RG's 13F filing for Q3 2017, filed 13 Nov 2017.